We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rising Demand for Surgical Drapes, Gowns, and Gloves

By HospiMedica staff writers
Posted on 10 Jul 2007
Rising awareness of nosocomial infections and an increase in surgical procedures is driving a demand for surgical drapes, gowns, and gloves. More...
These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

The European surgical drapes, gowns, and gloves markets are moving slowly toward maturity and are dominated by few large market participants. The growth rates for the market are modest, yet steady. In addition, the major factor driving market growth is the European medical directive EN 13795, which has set high standards of quality for surgical drapes and gowns. More often than not, these standards are met only by the disposable drapes and gowns market. As a result, the conversion to disposable surgical drapes and gowns is likely to gain momentum. On the other hand, the surgical gloves market has reached saturation in the powder-free segment and is expected to see conversion to synthetic alternatives.

Market participants will need to acquire or form alliances with companies that can help them broaden their product portfolio, rather than increase their market share. By expanding their product portfolio, companies will be able to participate in multi-product tenders, which help to reduce costs and provide multi-modal healthcare solutions.

"With challenges such as price erosion, consolidation and the search for cost-effective solutions, the markets are reaching a stage of saturation,” said Frost & Sullivan research analyst Ms. Sabita Ramachandran. "The decline in prices means that the profit margins of participants are limited and this is affecting R&D investments, which are crucial for maturing markets.”

Frost & Sullivan found that the surgical drapes, gowns and gloves markets in Europe earned revenues of US$751.6 million in 2006 and estimates this to reach $1.9 billion in 2013.


Related Links:
Frost & Sullivan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.